Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatotic liver disease.